Manufacture of pharmaceutical preparations
ABBOTT DIAGNOSTICS TECHNOLOGIES AS
Revenue 2024
NOK 2.0bn
Operating profit
NOK 435.4m
Equity
NOK 822.3m
Incorporated
1999
Employees
294
Share capital
NOK 2.0m
Key figures · 2024
Current ratio
1.08
Equity ratio
60.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 21.9% | |
| Net margin (%%) | 19.3% | |
| Return on assets (%%) | 32.1% | |
| Likviditet | ||
| Current ratio | 1.08 | |
| Working capital | 44.2m | |
| Soliditet | ||
| Equity ratio (%%) | 60.6% | |
| Debt-to-equity ratio | 0.65 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.